Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response (Q39149127)

9 September 2017

Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response (English)

1 reference

9 September 2017

0 references

0 references

Plasmodium falciparum

0 references

author

Georges Snounou

6

1 reference

9 September 2017

Sornchai Looareesuwan

8

object named as

Sornchai Looareesuwan

1 reference

9 September 2017

7

Nicholas J White

1 reference

9 September 2017

2

Mallika Imwong

1 reference

9 September 2017

Sasithon Pukrittayakamee

4

object named as

Sasithon Pukrittayakamee

1 reference

9 September 2017

3

Polrat Wilairatana

1 reference

9 September 2017

Sivicha Krudsood

1

1 reference

9 September 2017

Apichart Nonprasert

5

1 reference

9 September 2017

1 February 2005

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

9 September 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

9 September 2017

99

1 reference

9 September 2017

142-149

1 reference

9 September 2017

2

1 reference

Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Mutations in dhfr in Plasmodium falciparum infections selected by chlorproguanil-dapsone treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

The mode of action and the mechanism of resistance to antimalarial drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

The evolution of drug-resistant malaria: the role of drug elimination half-life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

A trial of proguanil-dapsone in comparison with sulfadoxine-pyrimethamine for the clearance of Plasmodium falciparum infections in Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Characterisation of the dihydrofolate reductase-thymidylate synthetase gene from human malaria parasites highly resistant to pyrimethamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

The mechanism of resistance to sulfa drugs in Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Antimalarial drug resistance: the pace quickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Antimalarial drug resistance and combination chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.07.001

10.1016/J.TRSTMH.2004.07.001

7 January 2021

Identifiers

DOI

1 reference

release_xmkdqu4k6vfxvdt6gemeohf5de

9 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xmkdqu4k6vfxvdt6gemeohf5de

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference